Skip to main content
Fig. 1 | BMC Neuroscience

Fig. 1

From: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies

Fig. 1

Immunocytochemical analysis of effects of CBL on levels of 3R Tau transgenic mice. a Immunocytochemistry with an antibody against 3R Tau in the 3–6 month group. b Image analysis of levels of 3R Tau immunoreactivity in the neocortex and hippocampus. c Immunocytochemistry with an antibody against 3R Tau in the 6–9 month group. d Image analysis of levels of 3R Tau immunoreactivity in the neocortex and hippocampus of the 6–9 month group. For analysis, N = 10 non-tg and N = 10 3R Tau tg mice from each age and treatment group. # P < 0.05 when compared to vehicle-treated tg mice control using one way ANOVA with Dunnet’s post hoc test

Back to article page

BMC Neuroscience

ISSN: 1471-2202

Contact us